Start Date
October 31, 1997
Primary Completion Date
January 31, 2003
Study Completion Date
doxorubicin hydrochloride
suramin
Mayo Clinic Cancer Center, Rochester
Lead Sponsor
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER